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DTable of ContentsCExpert Commentary 1101 Neutrophil gelatinase–associated lipocalin: A promising biomarker for
detecting cardiac surgery–associated acute kidney injury
Dinna N. Cruz, MD, Claudio Ronco, MD, and Nevin Katz, MD, Vicenza, Italy, and Washington, DCAcquired Cardiovascular
Disease (ACD)G
TS
ET
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S1107 Transapical transcatheter aortic valve implantation: Follow-up to 3 years
Jian Ye, MD, Anson Cheung, MD, Samuel V. Lichtenstein, MD, PhD, Fabian Nietlispach, MD,
Saad Albugami, MD, Jean-Bernard Masson, MD, Christopher R. Thompson, MD, Brad Munt, MD,
Robert Moss, MD, Ronald G. Carere, MD, W. R. Eric Jamieson, MD, and John G. Webb, MD,
Vancouver, British Columbia, Canada
We report clinical and echocardiographic outcomes of our first 71 patients having transapical AVI.
Overall survival at 36 months was 58.0%. Among 59 patients who survived 30 days, 36-month
survival was 69.8%. NYHA functional class improved significantly. Aortic valve area and mean
gradient remained stable up to 36 months.
1114 Effects of different annuloplasty rings on anterior mitral leaflet dimensions
Wolfgang Bothe, MD, John-Peder Escobar Kvitting, MD, PhD, Julia C. Swanson, MD,
Sigurd Hartnett, BA, Neil B. Ingels, Jr, PhD, andD. CraigMiller, MD, Standford and Palo Alto, Calif
Annuloplasty ring effect on anterior mitral leaflet (AML) dimensions and shape were assessed
in vivo. None changed AML shape. The Cosgrove ring did not affect AML dimensions, whereas rigid
complete rings (RSAR, Physio, IMR-ETlogix, and GeoForm) decreased AML commissure-
commissure dimensions at end diastole. Only the IMR-ETlogix and GeoForm rings reduced septal-
lateral AML dimension at end systole.
1123 Left ventricular surgical restoration for anteroseptal scars: Volume
versus shapeXAntonio M. Calafiore, MD, Angela L. Iaco`, MD, Davide Amata, MD, Cataldo Castello, MD, T
PMEgidio Varone, MD, Fabio Falconieri, MD, Antonio Bivona, MD, Sabina Gallina, MD, and
Michele Di Mauro, MD, Riyadh, Kingdom of Saudi Arabia; and Catania, Chieti, and Bari, Italy
Long-term results of left ventricular surgical restoration inwhich2different strategieswereused (restoration
of left ventricular volume or of left ventricular shape) were evaluated. When the main target of surgical
intervention is left ventricular reshaping rather than volume reduction, early and late outcomes improve.
1131 Electrophysiologic efficacy of irrigated bipolar radiofrequency in the
clinical setting
Stefano Benussi, MD, PhD, Andrea Galanti, MD, Valerio Zerbi, Ylenia A. Privitera,
Ida Iafelice, MD, and Ottavio Alfieri, MD, Milan, Italy
We investigated pulmonary vein isolation after surgical ablationwith irrigated bipolar radiofrequency.
Acute isolation required 3 6 1 encircling ablations. At 3 weeks, significant conduction block was
found in 85% of the patients. Intraoperative validation and/or multiple ablations are advisable.(continued on page 14A)
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PM1137 Is early antithrombotic therapy necessary in patients with bioprosthetic aortic
valves in normal sinus rhythm?
Andrew W. ElBardissi, MD, MPH, Daniel J. DiBardino, MD, Frederick Y. Chen, MD, PhD,
Michael H. Yamashita, MD, and Lawrence H. Cohn, MD, Boston, Mass
Current recommendations for anticoagulation after bioprosthetic aortic valve replacement include
either warfarin or aspirin for 90 postoperative days. In this study, we identify that widespread use of
anticoagulation after bioprosthetic aortic valve replacement is not indicated and that female patients,
those who undergo 19-mm aortic valve replacements, and those with depressed left ventricular
function are most likely to benefit from immediate postoperative antithrombotic therapy.
1146 The implementation of a comprehensive clinical protocol improves long-term
success after surgical treatment of atrial fibrillation
Niv Ad, MD, Linda Henry, PhD, RN, Sharon Hunt, MBA, and Lori Stone, BS, Falls Church, Va
The surgical ablation procedure was performed by multiple surgeons on 366 patients. A clinical
algorithm was used to address atrial arrhythmias when captured, and its effect was assessed. After
controlling for age, duration of atrial fibrillation, and left atrial size, the success rate was significantly
higher for those followed according to the protocol.
1153 Factors favoring stent-graft collapse after thoracic endovascular aortic repair
Ludovic Canaud, MD, Pierre Alric, MD, PhD, Pascal Desgranges, MD, PhD, Jean Marzelle, MD,
Charles Marty-Ane´, MD, PhD, and Jean-Pierre Becquemin, MD, Montpellier and Cre´teil, France
We report 4 cases of stent-graft collapse among 285 patients treated by thoracic endovascular aortic
repair.We assessed potential causative factors of stent-graft collapse after thoracic endovascular aortic
repair. This stent-graft–related complication seems related to poor apposition of the stent grafts in the
highly angulated aortic arch. Excessive stent-graft oversizing could be an additional causative factor.
1158 Meta-analysis of randomized trials on the efficacy of posterior pericardiotomy
in preventing atrial fibrillation after coronary artery bypass surgery
Fausto Biancari, MD, PhD, and Muhammad Ali Asim Mahar, MBBS, Oulu, Finland
Meta-analysis of 6 prospective randomized studies on the use of posterior pericardiotomy during
CABG demonstrates that this method is associated with a significant reduction postoperative AF,
supraventricular arrhythmias, and early and late pericardial effusion.
1162 Miniaturized cardiopulmonary bypass improves short-term outcome in cardiac
surgery: A meta-analysis of randomized controlled studies
Alberto Zangrillo, MD, Francesco Alfredo Garozzo, MD, Giuseppe Biondi-Zoccai, MD,
Federico Pappalardo, MD, Fabrizio Monaco, MD, Martina Crivellari, MD, Elena Bignami, MD,
Massimiliano Nuzzi, MD, and Giovanni Landoni, MD, Milan and Turin, Italy
In a meta-analysis of 16 randomized trials, we found that miniaturized cardiopulmonary bypass has
beneficial effects resulting in decreased transfusion rate and cardiac and neurologic damage when
compared with standard cardiac surgery.
1170 The influence of postoperative mitral valve function on the late recurrence of
atrial fibrillation after the maze procedure combined with mitral valvuloplasty
Joon Bum Kim, MD, Seung Hyun Lee, MD, Sung Ho Jung, MD, Sung Cheol Yun, PhD,
Suk JungChoo,MD,CheolHyunChung,MD,Hyun Song,MD, and JaeWonLee,MD, Seoul, SouthKorea
Late recurrence of atrial fibrillation after the maze procedure and concomitant mitral valve repair was
analyzed to investigate the influence of postoperative mitral valve dysfunction on atrial fibrillation
recurrence. As a result, the outcomes were negatively affected by postoperative mitral valve disease
after mitral valvuloplasty, as evidenced by greater atrial fibrillation recurrence.(continued on page 16A)
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Disease (CHD)16A The Journal of Thoracic an1177 Dextrocardia in patients with Poland syndrome: Phenotypic characterization
provides insight into the pathogenesis
Michele Torre, MD, Anwar Baban, MD, Anna Buluggiu, MD, Sara Costanzo, Lara Bricco, MD,
Margherita Lerone, MD, Sebastiano Bianca, MD, Gian Luca Gatti, MD, Filippo Maria Se´ne`s, MD,
Maura Valle, MD, and Maria Grazia Calevo, PhD, Genova, Catania, and Pisa, Italy
Analyzing 122 patients with Poland syndrome, dextrocardia occurred in 100% of patients with left-
sided multiple-rib partial agenesis. Dextrocardia was never associated with the other forms of the
syndrome. These findings suggest that the heart could be displaced to the right side by mechanical
factors during embryonic life.
1183 Avoiding cardiopulmonary bypass in extracardiac cavopulmonary connection:
Does it really matter?
Mohammad Ali Navabi, MD, SaidehM. Rastegar, MSN, Abdolrazagh Kiani, MD, Mahmood GholamAle Mohammad, MD, Parvin Akbari Asbagh, MD, Mohammad Reza Mirzaaghayan, MD,
Ali Pasha Meysamie, PhD, and Reza Shabanian, MD, Tehran, Iran
Avoiding cardiopulmonary bypass in fenestrated extracardiac total cavopulmonary connection had
no direct effect on the early outcome variables.
1189 Results after mitral valve replacement with mechanical prostheses in young
children
Bahaaldin Alsoufi,MD, CedricManlhiot, BSc, BrianW.McCrindle,MD,MPH, Zohair Al-Halees,MD,
Ahmed Sallehuddin, MD, Saud Al-Oufi, MD, Elias Saad, MD, Bahaa Fadel, MD, and
Charles C. Canver, MD, Riyadh, Saudi Arabia, and Toronto, Ontario, Canada
Competing-risks analysis of 79 children younger than 8 years who required mitral valve replacement
with mechanical prostheses revealed high early-phase mortality risk especially in younger patients
receiving significantly oversized valves and constant attrition rate from valve-related morbidity.
Repeated valve replacement was associated with young age at time of initial replacement.
1197 Right ventricular failure secondary to chronic overload in congenital heart
disease: An experimental model for therapeutic innovation
Virginie Lambert, MD, PhD, Andre´ Capderou, MD, PhD, Emmanuel Le Bret, MD, PhD,
Catherine Ru¨cker-Martin, PhD, Edith Deroubaix, PhD, Elodie Gouadon, PhD,
Nicolas Raymond, BSc, Bertrand Stos, MD, Alain Serraf, MD, PhD, and
Jean-Franc¸ois Renaud, PhD, Le Plessis Robinson and Orsay, France
Evolving RV alterations of repaired tetralogy of Fallot with usual sequelae were reproduced in
a porcine model. The functional and cellular aspects of early RV remodeling secondary to chronic
volumetric and barometric overload were assessed, and this model is applicable for therapeutic
innovation.
1205 Center variation and outcomes associated with delayed sternal closure after
stage 1 palliation for hypoplastic left heart syndrome
Jason N. Johnson, MD, James Jaggers, MD, Shuang Li, MS, Sean M. O’Brien, PhD,
Jennifer S. Li, MD, MHS, Jeffrey P. Jacobs, MD, Marshall L. Jacobs, MD, Karl F. Welke, MD,
Eric D. Peterson, MD, MPH, and Sara K. Pasquali, MD, Durham, NC, St Petersburg and Tampa,
Fla, Cleveland, Ohio, and Portland, Ore
We evaluated center variation in delayed sternal closure and associated outcomes after stage 1
palliation for hypoplastic left heart syndrome using the Society of Thoracic Surgeons Congenital
Database. Use of delayed sternal closure varies widely, and more frequent use was associated with
prolonged length of stay and more postoperative infection.(continued on page 18A)
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18A The Journal of Thoracic an1211 Hybrid procedure as an alternative to surgical palliation of high-risk infants
with hypoplastic left heart syndrome and its variants
Prem S. Venugopal, MCh, FRCS, Karyn P. Luna, MD, David R. Anderson, FRCS,
Conal B. Austin, FRCS, Eric Rosenthal, FRCP, MRCPCH, Thomas Krasemann, MD, and
Shakeel A. Qureshi, FRCP, London, United Kingdom
We are reporting our experience with hybrid strategy for management of high-risk patients with
HLHS and its variants and the option of biventricular repair in patients with borderline LV
dimensions using this approach.General Thoracic
Surgery (GTS)1216 Comparative glycomic profiling in esophageal adenocarcinoma
Zane T. Hammoud, MD, Yehia Mechref, PhD, Ahmed Hussein, PhD, Slavka Bekesova, PhD,
Min Zhang, PhD, Kenneth A. Kesler, MD, and Milos V. Novotny, PhD, Detroit, Mich; and
Bloomington and Indianapolis, Ind
Serum glycomic analysis was performed in esophageal adenocarcinoma and precursor lesions.
Altered glycosylation may diagnose adenocarcinoma, and a subset of glycans may be selected as
candidate biomarkers.1224 Combined proteasome and histone deacetylase inhibition attenuates epithelial–
mesenchymal transition through E-cadherin in esophageal cancer cells
Matthew D. Taylor, MD, Yuan Liu, MD, PhD, Alykhan S. Nagji, MD, Nicholas Theodosakis, BS, and
David R. Jones, MD, Charlottesville, Va
Combined vorinostat and bortezomib therapy significantly decreased esophageal cancer epithelial–
mesenchymal transition. This combined therapeutic effect on esophageal cancer epithelial–
mesenchymal transition was associated with upregulation of E-cadherin protein expression.1233 Combined treatment with cisplatin and sirolimus to enhance cell death in
human mesothelioma
Mor-Li Hartman, PhD, John Matthew Esposito, BA, Beow Yong Yeap, ScD, and David John
Sugarbaker, MD, Boston, Mass
Cisplatin is widely used in malignant pleural mesothelioma but has modest therapeutic effect.
We studied the efficacy of combination treatment with sirolimus and cisplatin. This treatment
significantly increased cell death in mesothelioma cell lines, decreased cell proliferation in human
tumors versus either drug alone, and affected the Akt/mTOR pathway.1241 Is prophylactic treatment of contralateral blebs in patients with primary
spontaneous pneumothorax indicated?
Shah-Hwa Chou, MD, Hsien-Pin Li, MD, Jui-Ying Lee, MD, Shun-Jen Chang, MD,
Yen-Lung Lee, MD, Yu-Tang Chang, MD, Eing-Long Kao, MD, Zen-Kong Dai, MD, and
Meei-Feng Huang, RN, Kaohsiung, Taiwan
Around half of the patients who present with primary spontaneous pneumothorax have contralateral
blebs, and a quarter will develop contralateral pneumothorax. Our study showed that preemptive
video-assisted thoracic surgery for the contralateral blebs/bullae effectively prevented the
contralateral occurrence.(continued on page 20A)
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20A The Journal of Thoracic an1246 The impact on survival of positive intraoperative pleural lavage cytology in
patients with non–small-cell lung cancer
Keiju Aokage, MD, Junji Yoshida, MD, Genichiro Ishii, MD, Sotarou Enatsu, MD,Tomoyuki Hishida, MD, Mitsuyo Nishimura, MD, Yutaka Nishiwaki, MD, and Kanji Nagai, MD,
Chiba, Japan
Pleural lavage cytology (PLC) was obtained during NSCLC resection and its effect on survival was
evaluated. PLC after resection was a more useful prognostic factor than PLC before resection. Almost
all patients with positive PLC after resection relapsed within 5 years. Positive post-PLC disease
should be classified as pathologic T4 and managed similarly to dissemination.Evolving Technology/
Basic Science (ET/BS)1253 Genomic characterization of the inflammatory response initiated by surgical
intervention and the effect of perioperative cyclooxygenase 2 blockade
Keith D. Coon, PhD, Landon J. Inge, PhD, Kristen Swetel, Valerie Felton, Phillip Stafford, PhD, and
Ross M. Bremner, MD, PhD, Phoenix and Tempe, Ariz
Surgery is known to induce stress, but the result of surgical stress has yet to be elucidated at the
molecular level. Here, we show the effect of surgical stress on gene expression. Additionally, we
demonstrate that gene expression changes caused by surgical stress can be chemically modulated.
1261 Augmentation of systemic blood pressure during spinal cord ischemia to prevent
postoperative paraplegia after aortic surgery in a rabbit model
So Izumi, MD, Kenji Okada, MD, Tomomi Hasegawa, MD, Atsushi Omura, MD,
Hiroshi Munakata, MD, Masamichi Matsumori, MD, and Yutaka Okita, MD, Kobe, Japan
Effects of systemic hypertension during aortic crossclamping on spinal cord were evaluated in
a rabbit transient spinal cord ischemia model. Ischemic insult to spinal cord was attenuated with
systemic hypertension during aortic crossclamping. Systemic blood pressure augmentation during
spinal cord ischemia can reduce postoperative neurologic adverse events.
1269 Left atrial appendage clip occlusion: Early clinical results
Sacha P. Salzberg, MD, Andre Plass, MD, Maximillian Y. Emmert, MD, Lotus Desbiolles, MD,
Hatem Alkadhi, MD, Jurg Gru¨nenfelder, MD, and Michele Genoni, MD, Zurich, Switzerland
A new clip device for epicardial left atrial appendage occlusion was evaluated with regard to safety
and effectiveness in patients with atrial fibrillation undergoing cardiac surgery. Early postoperative
and 3 month follow-up computed tomography studies were used to assess clip location and left atrial
appendage perfusion. Thirty-four patients underwent successful clip placement. No device-related
complications occurred, and serial computed tomography scans demonstrated stable clip location and
no left atrial appendage perfusion at 3 months in all patients. This report demonstrates safe, effective,
and durable left atrial appendage occlusion with this new clip.
1275 Simulation in coronary artery anastomosis early in cardiothoracic surgical
residency training: The Boot Camp experience
James I. Fann, MD, John H. Calhoon, MD, Andrea J. Carpenter, MD, PhD, Walter H. Merrill, MD,
John W. Brown, MD, Robert S. Poston, MD, Maziyar Kalani, BS, Gordon F. Murray, MD,
George L. Hicks, Jr, MD, and Richard H. Feins, MD, Stanford and Palo Alto, Calif; San Antonio,
Tex; Cincinnati, Ohio; Indianapolis, Ind; Boston, Mass; Morgantown, WV; Rochester, NY; and
Chapel Hill, NC
We evaluated focused training of 33 cardiothoracic surgical residents in a 4-hour coronary
anastomosis session. According to a global rating scale, residents demonstrated improved ability to
perform anastomoses. This ‘‘Boot Camp’’ may be useful in preparing residents for coronary
anastomosis, but emphasis on simulation development and deliberate practice is necessary.(continued on page 21A)
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Table of Contents (continued)1282 Excision of atrial myxoma using robotic technology
Changqing Gao, MD, Ming Yang, MD, Gang Wang, MD, Jiali Wang, MD, Cangsong Xiao, MD,
Yang Wu, MD, and Jiachun Li, BS, Beijing, China
Nineteen consecutive patients underwent complete resection of atrial myxomas with the da Vinci S
Surgical System. Via 4 port incisions and a 1.5-cm working port, all the procedures were completed
with the robot. Resection was successful in all patients. There were no complications. Follow-up
shows that surgical results are excellent.
1286 Aging impairs the angiogenic response to ischemic injury and the activity of
implanted cells: Combined consequences for cell therapy in older recipients
Yufeng Zhuo, MD, Shu-Hong Li, MD, MSc, Min-Sheng Chen, MD, Jun Wu, MD,
Heather Y. McDonald Kinkaid, MSc, Shafie Fazel, MD, PhD, Richard D. Weisel, MD, and
Ren-Ke Li, MD, PhD, Toronto, Ontario, Canada, and Guangzhou, China
We show the effects of aging on the response to ischemic injury and the activity of implanted bone
marrow cells in the context of cell therapy for older recipients. The ages of the implanted cells and the
cell recipients may contribute equally to the degree of regional perfusion restoration.G
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PM1295 Bridge to transplant experience: Factors influencing survival to and after
cardiac transplant
Nicholas G. Smedira, MD, Katherine J. Hoercher, RN, Dustin Y. Yoon, MS,
Jeevanantham Rajeswaran, MSc, Lynne Klingman, MT, CHS, Randall C. Starling, MD, MPH, and
Eugene H. Blackstone, MD, Cleveland, Ohio
Initiating mechanical circulatory support early with a single definitive device may improve survival
to and after cardiac transplantation. Early transplant, which avoids infection, sensitization, and
neurologic complications, may improve bridge and transplant survival.
1306 Lung transplantation with donation after cardiac death donors: Long-term
follow-up in a single center
Nilto C. De Oliveira, MD, Satoru Osaki, MD, PhD, James D. Maloney, MD, Keith C. Meyer, MD,
Takushi Kohmoto, MD, PhD, Anthony M. D’Alessandro, MD, and Robert B. Love, MD, Madison,
Wis, and Maywood, Ill
This study examines a single-center experience in lung transplantation from donation after cardiac
death (DCD) donors. Eighteen patients received transplants from DCD donors, and long-term
survival was equivalent to that seen in patients receiving allografts from brain-dead donors. DCD
donors can safely and substantially expand the donor pool for lung transplantation.
1316 Right ventricular failure in patients with the HeartMate II continuous-flow left
ventricular assist device: Incidence, risk factors, and effect on outcomes
Robert L. Kormos, MD, Jeffrey J. Teuteberg, MD, Francis D. Pagani, MD, Stuart D. Russell, MD,
Ranjit John, MD, Leslie W. Miller, MD, Todd Massey, MD, Carmelo A. Milano, MD,
Nader Moazami, MD, Kartik S. Sundareswaran, PhD, and David J. Farrar, PhD, for the
HeartMate II Clinical Investigators, Pittsburgh, Pa; Ann Arbor, Mich; Baltimore, Md; Minneapolis,
Minn; Washington, DC; Rochester, NY; Durham, NC; St Louis, Mo; and Pleasanton, Calif
The incidence, outcomes, and risk factors of right ventricular failure (RVF) in a large population of
patients with continuous-flow left ventricular assist devices were evaluated. Patients with RVF had
worse outcomes than patients without RVF and hence might benefit from preoperative right heart
optimization or planned biventricular support.(continued on page 22A)
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Management (PM)22A The Journal of Thoracic an1325 Successful resuscitation after prolonged periods of cardiac arrest: A new field in
cardiac surgery
Georg Trummer, MD, Katharina Foerster, MD, Gerald D. Buckberg, MD, Christoph Benk, MD,
Claudia Heilmann, MD, Irina Mader, MD, Friedrich Feuerhake, MD, Oliver Liakopoulos, MD,
Kerstin Brehm, MD, and Friedhelm Beyersdorf, MD, Freiburg, Germany, and Los Angeles, Calif
Cardiopulmonary resuscitation is associated with high mortality and poor neurological recovery.
We used cardiopulmonary bypass in a survival model in pigs to limit whole-body
ischemia–reperfusion injury after 15 minutes of normothermic ischemia. We observed 100% survival
and clinically apparent neurological recovery, whereas all animals in the control group died.1333 Survival of patients on dialysis having off-pump versus on-pump coronary
artery bypass surgery in the United States
Gautam R. Shroff, MD, Shuling Li, MS, and Charles A. Herzog, MD, Minneapolis, Minn
To compare outcomes between off-pump CABG and on-pump CABG surgery in patients on dialysis,
13,085 patients on dialysis having first CABG between 2001 and 2006 were identified; 2335 (17.8%)
had off-pump CABG. Off-pump CABGwas associated with significantly reduced all-cause mortality
compared with on-pump CABG, most notably in the first year after surgery.Brief Technique Reports 1339 Bilateral pulmonary artery banding for extremely low birth weight infants with
coarctation or interruption of the aorta weighing less than 1.0 kg
Yoichi Kawahira, MD, Kyoichi Nishigaki, MD, and Yoshito Maehata, MD, Osaka, Japan1340 Aortic cusp repair with Gore-Tex sutures during aortic valve–sparing
operations
Tirone E. David, MD, and Susan Armstrong, MSc, Toronto, Ontario, Canada1343 A novel running annuloplasty suture technique for robotically assisted mitral
valve repair
Tomislav Mihaljevic, MD, Craig M. Jarrett, MD, MBA, A. Marc Gillinov, MD, and
Eugene H. Blackstone, MD, Cleveland, Ohio1345 Polymer self-locking clips for vascular control during minimally invasive
pulmonary lobectomies
Marco Lucchi, MD, Leonardo Duranti, MD, Franca Melfi, MD, and Alfredo Mussi, MD, Pisa, Italy1346 The option of taking down the Fontan circulation: The Melbourne experience
Ajay J. Iyengar, MBBS, BMedSci, Christian P. Brizard, MD, MS, Igor E. Konstantinov, MD, PhD,
and Yves d’ Udekem, MD, PhD, Melbourne, Australia1349 Feasibility of transtracheal thoracoscopy (natural orifice transluminal
endoscopic surgery)
Yun-Hen Liu, MD, Hung-Ping Liu, MD, Yi-Chen Wu, MD, and Po-Jen Ko, MD, Taiwan, China(continued on page 23A)
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Table of Contents (continued)Brief Research Report 1351 Increased late mortality with percutaneous stenting for unprotected left
main coronary artery stenosis relative to coronary artery bypass grafting:
A meta-analysis of observational studies
Hisato Takagi, MD, PhD, Masafumi Matsui, MD, and Takuya Umemoto, MD, PhD, Shizuoka, JapanDOnline Only: Brief
Clinical ReportsCH
G
TSe97 Kommerell diverticulum, right-sided aorta, and left aberrant subclavian artery
in a patient with dysphagia
Jenn-Yu Wu, MD, Hsin-Yi Chen, MD, Chin-Chung Shu, MD, and Chong-Jen Yu, MD, PhD, Yun-Lin
and Taipei, Taiwan
e99 Late fulminant pulmonary valve endocarditis after the Ross operation
Giovanni Melina, PhD, Ismail El-Hamamsy, MD, Riccardo Sinatra, PhD, and
Magdi H. Yacoub, FRS, Rome, Italy, and London, United Kingdom
e100 Subepicardial congenital vascular malformation mimicking a bulky tumor with
severe compression of the right heart chambers
Naser Qedra, MD, Takeshi Komoda, MD, Marian Kukucka, MD, and Roland Hetzer, MD, PhD,
Berlin, Germany
e103 Transection with pseudoaneurysm formation of the pulmonary trunk after
placement of an adjustable pulmonary artery banding device (FloWatch-PAB)
in a patient with residual muscular ventricular septal defectET
/B
SPrem S. Venugopal, MCh, FRCS, Nicholas Hayes, MRCPCH, John Simpson, FRCP, and
David Anderson, FRCS, London, United Kingdom
e104 An adult man presenting with hemoptysis caused by mature teratoma with
rupture into the bronchus and pericardium and complicated by Haemophilus
influenzae infection
Karthik Jothianandan, MD, Amit S. Tibb, MD, Michael McLemore, MD, Steven Keller, MD, and
David W. Appel, MD, Bronx, NY
e108 Clear cell sugar tumor of the lung masquerading as tuberculosis in a pediatric
patient
Deepika Nehra, MD, Parsia A. Vagefi, MD, Henry Chang, MD, Abner Louissaint, MD,
Mari Mino-Kenudson, MD, and Daniel P. Ryan, MD, Boston, Mass
e110 Unilateral left lung agenesis with crossed-ectopic right lower lobe combined
tricuspid atresia diagnosed by ECG gated computed tomographyTXLi-Lan Chiang, MD, Shuenn-Nan Chiu, MD, Shu-Chien Huang, MD, and Shy-Jye Chen, MD, Taipei,
TaiwanPM
e112 Living-donor single-lobe lung transplant in a 6-year-old girl after 7-month
mechanical ventilator support
Tsuyoshi Shoji, MD, Toru Bando, MD, Takuji Fujinaga, MD, and Hiroshi Date, MD, Kyoto, Japan
e114 Tricuspid valve replacement and ventricular septal defect repair in a patient
with Glanzmann thrombasthenia
Jake Gillen, BS, John Lazarchick, MD, and Fred A. Crawford, Jr, MD, Charleston, SC
e115 Surviving a transfixing cardiac injury caused by a stingray barb
Michael W. Parra, MD, Eugene N. Costantini, MD, FACS, Edgar B. Rodas, MD,
Pedro J. Gonzalez, MD, Omar J. Salamen, DDS, Joseph D. Catino, MD, Paul M. Taber, RN, BSN,
and Ivan Puente, MD, FACS, Fort Lauderdale, Fla(continued on page 24A)
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Table of Contents (continued)Letters to the Editor24A The Journal of Thoracic an1354 Aortic bioprosthesis—avoid obstructive properties due to thrombosis as altered
durability due to structural valve deterioration
W. R. Eric Jamieson, MD, and Guy J. Fradet, MD, Vancouver, British Columbia, Canada
1354 Interpreting a 20-year experience with the Biocor porcine bioprosthesis
Willem J. L. Suyker, MD, PhD, and Frans G. Leicher, MD, Zwolle, The Netherlands
1355 The second assistant in cardiac surgery
T. K. Susheel Kumar, MD, Washington, DC
1356 Hydrodynamic performance of heart valve prostheses: Open discussion on
European Committee for Standardization International Organization for
Standardization standard 5840
Francesca Maria Susin, PhD, Andrea Bagno, PhD, and Gino Gerosa, MD, Padua, Italy
1357 Bonanno’s catheter: A less invasive and cost-effective alternative for drainage of
pleural effusion
Annabel Sharkey, MBChB, Sheffield, South Yorkshire, United Kingdom
1357 Hypoxemic reperfusion of ischemic states prevents myocardial injury,
attenuating the oxidative and inflammatory response
Emmanuel E. Douzinas, MD, Marios-Konstantinos Tasoulis, MD, and Alex Betrosian, MD,
Athens, Greece
1358 Hypouricemic effect of statins: Another pleiotropic benefit?
A´ngel Lo´pez-Cuenca, MD, Vanessa Rolda´n, MD, PhD, and Francisco Marı´n, MD, PhD,
Murcia, Spain
1359 Extending the suitability of endovascular therapies during type A acute aortic
dissection repair
Mattia Glauber, MD, and Michele Murzi, MD, Massa, Italy
1360 Reply to the Editor
LiZhong Sun, MD, and RuiDong Qi, MD, Beijing and Tianjin, China
1360 Is a transannular patch always necessary?
Mert Kestelli, MD, Ismail Yurekli, MD, and Ali Gurbuz, MD, Izmir, Turkey
1361 Reply to the Editor
Gianluca Brancaccio, MD, PhD, Vincenzo Affinito, MD, and Roberto M. Di Donato, MD,
Rome, ItalyMeetings and Courses 1362 Meetings and CoursesAnnouncements The American Association for Thoracic Surgery
1363 AATS 90th Annual Meeting
1363 AATS Meetings and Sponsored Events(continued on page 26A)
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26A The Journal of Thoracic an1364 2010 Heart Valve Summit: Medical, Surgical, and Interventional Decision Making
1364 AATS Online Award Applications Now Available at www.aats.org
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1365 WTSA 36th Annual Meeting
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